tb500 bpc 157 topical gel BPC-157 / TB-500 Transdermal tb-500 bpc 157 topical gel
Description
Not for human or veterinary use, consumption, administration, diagnosis, treatment or any clinical purpose
It is a multicenter randomized double-blind placebo-controlled phase 3 study evaluating the safety and efficacy of two IV doses of Efzofitimod (3 and 5 mg/kg) given every 4 weeks to patients with pulmonary sarcoidosis receiving stable doses of oral corticosteroids taken with or without additional immunosuppressant therapy (237)
Will I feel worse before I feel better
c-Met and PD-L1 on circulating exosomes as diagnostic and prognostic markers for pancreatic cancer
